Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medi-Flex, which later rebranded as Enturia, was a healthcare company specializing in infection prevention products, most notably the ChloraPrep skin antiseptic system. The company developed a proprietary applicator technology that delivers a combination of chlorhexidine gluconate and isopropyl alcohol, which became a clinical standard for preoperative skin preparation. Its products are designed to reduce the risk of healthcare-associated infections, including surgical site infections and bloodstream infections. The company was acquired by Cardinal Health in 2008 for approximately $490 million, and its core product line is now part of Becton, Dickinson and Company (BD).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medi-Flex.